Log In
BCIQ
Print this Print this
 

Adenosine A3 receptor (ADORA3)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Adenosine A3 receptor (ADORA3)

BCIQ
Print ChartPrint this
Phase II/III, 1 Phase II, 1 Phase II, 1 Phase II, 1 Phase I, 1 Phase I, 1 Preclinical, 2 Preclinical, 1 Preclinical, 1 Preclinical, 1 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase IIPhase II/III
Autoimmune

1

1

1

1

Cancer

-

-

1

-

Genitourinary

1

-

-

-

Hepatic

1

-

-

-

Inflammation

1

-

-

-

Ophthalmic

2

1

1

-




 Products Targeting Adenosine A3 receptor (ADORA3)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$2.9M

$1.3M

$2.8M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today